Festival of Genomics

January 23rd - 24th, 2019

Business Design Centre, London

SPEAKERS

The Festival has really captured the imagination of leading scientists – particularly in the UK. So much so, that increasingly we are lucky to attract incredible speakers who hugely enrich the experience of our attendees. This year is stronger than ever – and we’ve only just begun to confirm speakers.

That said, the UK has become a hot-bed of activity and innovation in genomics, with the NHS leading the way, supported by the UK government. This year, we have much more representation from the NHS and the UK healthcare system, including Sue Hill, Chief Scientific Officer of NHS England, plus crucial updates on the roll-out of the NHS Genomic Medicine Service, and more involvement from the NHS and UK healthcare trusts than ever before.

Representing the UK Government, we’re also proud to welcome Lord O’Shaughnessy, Parliamentary Under Secretary of State at the Department of Health, a longstanding advocate of advancing the UK’s genomics capabilities.

On top of the amazing clinical-oriented speakers we’ve secured, we’re currently working hard to pack the agenda full of pharma, data, investment and technology leaders from across the UK and beyond.

As we approach Brexit, it’s even more important that we increase involvement from speakers and panellists outside of the UK. And that’s also reflected in the agenda, particularly in showcasing ground-braking genomics developments happening in Estonia, Finland and beyond.

Representing the UK Government, we’re also proud to welcome Lord O’Shaughnessy, Parliamentary Under Secretary of State at the Department of Health, a longstanding advocate of advancing the UK’s genomics capabilities.

On top of the amazing clinical-oriented speakers we’ve secured, we’re currently working hard to pack the agenda full of pharma, data, investment and technology leaders from across the UK and beyond.

As we approach Brexit, it’s even more important that we increase involvement from speakers and panellists outside of the UK. And that’s also reflected in the agenda, particularly in showcasing ground-braking genomics developments happening in Estonia, Finland and beyond.